CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: PX-866
Accession: CHEBI:65345
browse the term
Definition: An organic heterotetracyclic compound that is obtained from wortmanin via aminolysis of its furan ring by diallyl amine.
Synonyms: exact_synonym: (1E,4S,4aR,5R,6aS,9aR)-1-{[di(prop-2-en-1-yl)amino]methylidene}-11-hydroxy-4-(methoxymethyl)-4a,6a-dimethyl-2,7,10-trioxo-1,2,4,4a,5,6,6a,7,8,9,9a,10-dodecahydroindeno[4,5-h]isochromen-5-yl acetate
related_synonym: Formula=C29H35NO8; InChI=1S/C29H35NO8/c1-7-11-30(12-8-2)14-17-23-26(34)25(33)22-18-9-10-20(32)28(18,4)13-19(37-16(3)31)24(22)29(23,5)21(15-36-6)38-27(17)35/h7-8,14,18-19,21,34H,1-2,9-13,15H2,3-6H3/b17-14+/t18-,19+,21+,28-,29-/m0/s1; InChIKey=QIUASFSNWYMDFS-NILGECQDSA-N; SMILES=[H][C@@]12CCC(=O)[C@@]1(C)C[C@@H](OC(C)=O)C1=C2C(=O)C(O)=C2\\C(=C/N(CC=C)CC=C)C(=O)O[C@H](COC)[C@]12C
xref_mesh: MESH:C496788
xref: Reaxys:12534000
G
Akt1
AKT serine/threonine kinase 1
decreases phosphorylation multiple interactions
ISO
PX-866 results in decreased phosphorylation of AKT1 protein PX-866 inhibits the reaction [[Calcium co-treated with Ionomycin] results in increased phosphorylation of AKT1 protein]; PX-866 promotes the reaction [STO 609 results in decreased phosphorylation of AKT1 protein]; STO 609 promotes the reaction [PX-866 results in decreased phosphorylation of AKT1 protein]
CTD
PMID:25805502 PMID:28634229
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Axin2
axin 2
multiple interactions
ISO
[Raloxifene Hydrochloride co-treated with PX-866] results in decreased expression of AXIN2 mRNA
CTD
PMID:27017931
NCBI chr10:93,893,830...93,927,042
Ensembl chr10:93,899,245...93,926,231
G
Bad
BCL2-associated agonist of cell death
decreases phosphorylation multiple interactions
ISO
PX-866 results in decreased phosphorylation of BAD protein [PX-866 co-treated with BBR3610] results in decreased phosphorylation of BAD protein
CTD
PMID:20473884
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
G
Bhlhe40
basic helix-loop-helix family, member e40
multiple interactions
ISO
[Raloxifene Hydrochloride co-treated with PX-866] results in increased expression of BHLHE40 mRNA
CTD
PMID:27017931
NCBI chr 4:141,618,453...141,624,154
Ensembl chr 4:141,618,476...141,624,774
G
Camkk2
calcium/calmodulin-dependent protein kinase kinase 2
affects response to substance
ISO
CAMKK2 protein affects the susceptibility to PX-866
CTD
PMID:28634229
NCBI chr12:33,791,023...33,845,000
Ensembl chr12:33,791,052...33,843,279
G
Ccnd1
cyclin D1
multiple interactions
ISO
[Raloxifene Hydrochloride co-treated with PX-866] results in decreased expression of CCND1 mRNA
CTD
PMID:27017931
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
G
Ccne2
cyclin E2
decreases expression multiple interactions
ISO
PX-866 results in decreased expression of CCNE2 mRNA [Raloxifene Hydrochloride co-treated with PX-866] results in decreased expression of CCNE2 mRNA
CTD
PMID:26660119
NCBI chr 5:24,285,078...24,298,258
Ensembl chr 5:24,284,922...24,297,632
G
Cd36
CD36 molecule
multiple interactions
ISO
[PX-866 co-treated with SORT1 protein] results in decreased expression of CD36 mRNA
CTD
PMID:25805502
NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903
G
Cdc6
cell division cycle 6
multiple interactions decreases expression
ISO
[Raloxifene Hydrochloride co-treated with PX-866] results in decreased expression of CDC6 mRNA PX-866 results in decreased expression of CDC6 mRNA
CTD
PMID:26660119
NCBI chr10:83,864,189...83,878,011
Ensembl chr10:83,864,638...83,878,011
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
multiple interactions
ISO
[Raloxifene Hydrochloride co-treated with PX-866] results in increased expression of CDKN1A mRNA
CTD
PMID:27017931
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Cyp7a1
cytochrome P450 family 7 subfamily A member 1
multiple interactions
ISO
[PX-866 co-treated with SORT1 protein] results in decreased expression of CYP7A1 mRNA
CTD
PMID:25805502
NCBI chr 5:19,376,979...19,386,676
Ensembl chr 5:19,376,974...19,386,688
G
E2f1
E2F transcription factor 1
multiple interactions
ISO
[Raloxifene Hydrochloride co-treated with PX-866] results in decreased expression of E2F1 mRNA
CTD
PMID:26660119
NCBI chr 3:143,064,535...143,075,362
Ensembl chr 3:143,049,478...143,075,361
G
Fasn
fatty acid synthase
multiple interactions
ISO
PX-866 promotes the reaction [SORT1 protein results in decreased expression of FASN mRNA]
CTD
PMID:25805502
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
G
Hbegf
heparin-binding EGF-like growth factor
multiple interactions
ISO
[Raloxifene Hydrochloride co-treated with PX-866] results in decreased expression of HBEGF mRNA
CTD
PMID:27017931
NCBI chr18:28,106,284...28,116,167
Ensembl chr18:28,105,760...28,116,441
G
Il11
interleukin 11
multiple interactions
ISO
[Raloxifene Hydrochloride co-treated with PX-866] results in decreased expression of IL11 mRNA
CTD
PMID:26660119
NCBI chr 1:69,069,829...69,076,129
Ensembl chr 1:69,068,137...69,076,129
G
Lif
LIF, interleukin 6 family cytokine
multiple interactions
ISO
[Raloxifene Hydrochloride co-treated with PX-866] results in decreased expression of LIF mRNA
CTD
PMID:27017931
NCBI chr14:79,131,049...79,140,486
Ensembl chr14:79,134,574...79,140,482
G
Mdm2
MDM2 proto-oncogene
decreases phosphorylation multiple interactions
ISO
PX-866 results in decreased phosphorylation of MDM2 protein [Raloxifene Hydrochloride co-treated with PX-866] results in decreased phosphorylation of MDM2 protein
CTD
PMID:27017931
NCBI chr 7:53,290,660...53,315,205
Ensembl chr 7:53,290,664...53,314,915
G
Mttp
microsomal triglyceride transfer protein
multiple interactions
ISO
PX-866 promotes the reaction [SORT1 protein results in decreased expression of MTTP mRNA]
CTD
PMID:25805502
NCBI chr 2:226,613,090...226,654,239
Ensembl chr 2:226,613,090...226,654,239
G
Rb1
RB transcriptional corepressor 1
multiple interactions
ISO
[Raloxifene Hydrochloride co-treated with PX-866] results in decreased phosphorylation of RB1 protein
CTD
PMID:26660119
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
G
Scd
stearoyl-CoA desaturase
multiple interactions
ISO
PX-866 promotes the reaction [SORT1 protein results in decreased expression of SCD1 mRNA]
CTD
PMID:25805502
NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562
G
Sort1
sortilin 1
multiple interactions decreases expression
ISO
[PX-866 co-treated with SORT1 protein] results in decreased expression of CD36 mRNA; [PX-866 co-treated with SORT1 protein] results in decreased expression of CYP7A1 mRNA; PX-866 promotes the reaction [SORT1 protein results in decreased expression of FASN mRNA]; PX-866 promotes the reaction [SORT1 protein results in decreased expression of MTTP mRNA]; PX-866 promotes the reaction [SORT1 protein results in decreased expression of SCD1 mRNA]; SORT1 protein inhibits the reaction [PX-866 results in increased abundance of Triglycerides] PX-866 results in decreased expression of SORT1 protein
CTD
PMID:25805502
NCBI chr 2:195,924,033...196,002,354
Ensembl chr 2:195,924,099...196,002,354
G
Tert
telomerase reverse transcriptase
multiple interactions
ISO
[Raloxifene Hydrochloride co-treated with PX-866] results in decreased expression of TERT mRNA
CTD
PMID:27017931
NCBI chr 1:29,637,213...29,659,561
Ensembl chr 1:29,637,506...29,659,561
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all